Tretinoin and Arsenic Trioxide in Patients With Untreated Acute PML
Full IRB Study Title:
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-trans Retinoic Acid
IRB Study ID: 1099169
For complete information, please visit the study on clinicaltrials.gov
Study Sponsor:
Children's Oncology Group